Are We Ready for Biosimilars in Gastroenterology?
Biologics are large complex molecules that are produced in living systems. They have revolutionised the treatment of patients suffering from various diseases, including inflammatory bowel disease. However, in many parts of the world, patient access to biologics has been hampered, mainly because of t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-12-01
|
Series: | European Medical Journal Gastroenterology |
Subjects: | |
Online Access: | https://www.emjreviews.com/gastroenterology/article/are-we-ready-for-biosimilars-in-gastroenterology/ |